AMNEAL PHARMACEUTICALS INC. 2024-2025 Proxy Voting Records

Description as filed by funds: Election of Directors: Chintu Patel

AMNEAL PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Chintu Patel”): 259,451,886 for, 840,909 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the proposals was approved, and each of the director nominees was elected, by the vote of the stockholders at the Annual Meeting as follows: Proposal 1 : To elect the following director nominees to hold office until the 2025 Annual Meeting of Stockholders and until their respective successo…”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 44,840,134 for.

Showing the 25 largest of 74 asset managers. See all 74 in the interactive database.

Description as filed by funds: Election of Directors: Chirag Patel

AMNEAL PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Chirag Patel”): 259,263,024 for, 1,029,755 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the proposals was approved, and each of the director nominees was elected, by the vote of the stockholders at the Annual Meeting as follows: Proposal 1 : To elect the following director nominees to hold office until the 2025 Annual Meeting of Stockholders and until their respective successo…”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 44,656,989 for, 183,145 against.

Showing the 25 largest of 74 asset managers. See all 74 in the interactive database.

Description as filed by funds: Election of Directors: Deb Autor

AMNEAL PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Deb Autor”): 258,775,698 for, 1,519,874 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the proposals was approved, and each of the director nominees was elected, by the vote of the stockholders at the Annual Meeting as follows: Proposal 1 : To elect the following director nominees to hold office until the 2025 Annual Meeting of Stockholders and until their respective successo…”
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 44,650,934 for, 189,200 against.

Showing the 25 largest of 74 asset managers. See all 74 in the interactive database.

Description as filed by funds: Election of Directors: Emily Peterson Alva

AMNEAL PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Emily Peterson Alva”): 258,746,677 for, 1,549,356 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the proposals was approved, and each of the director nominees was elected, by the vote of the stockholders at the Annual Meeting as follows: Proposal 1 : To elect the following director nominees to hold office until the 2025 Annual Meeting of Stockholders and until their respective successo…”
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 44,650,934 for, 189,200 against.

Showing the 25 largest of 74 asset managers. See all 74 in the interactive database.

Description as filed by funds: Election of Directors: Gautam Patel

AMNEAL PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Gautam Patel”): 256,035,302 for, 4,257,416 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the proposals was approved, and each of the director nominees was elected, by the vote of the stockholders at the Annual Meeting as follows: Proposal 1 : To elect the following director nominees to hold office until the 2025 Annual Meeting of Stockholders and until their respective successo…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 44,402,402 for, 437,732 against.

Showing the 25 largest of 74 asset managers. See all 74 in the interactive database.

Description as filed by funds: Election of Directors: J. Kevin Buchi

AMNEAL PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: J. Kevin Buchi”): 257,353,899 for, 2,740,560 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the proposals was approved, and each of the director nominees was elected, by the vote of the stockholders at the Annual Meeting as follows: Proposal 1 : To elect the following director nominees to hold office until the 2025 Annual Meeting of Stockholders and until their respective successo…”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 44,296,364 for, 351,751 against, 192,019 abstained.

Showing the 25 largest of 74 asset managers. See all 74 in the interactive database.

Description as filed by funds: Election of Directors: Jeff George

AMNEAL PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Jeff George”): 258,597,328 for, 1,697,135 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the proposals was approved, and each of the director nominees was elected, by the vote of the stockholders at the Annual Meeting as follows: Proposal 1 : To elect the following director nominees to hold office until the 2025 Annual Meeting of Stockholders and until their respective successo…”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 44,650,934 for, 189,200 against.

Showing the 25 largest of 74 asset managers. See all 74 in the interactive database.

Description as filed by funds: Election of Directors: John Kiely

AMNEAL PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: John Kiely”): 257,525,966 for, 2,568,488 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the proposals was approved, and each of the director nominees was elected, by the vote of the stockholders at the Annual Meeting as follows: Proposal 1 : To elect the following director nominees to hold office until the 2025 Annual Meeting of Stockholders and until their respective successo…”
Support: 99.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 44,296,364 for, 351,751 against, 192,019 abstained.

Showing the 25 largest of 74 asset managers. See all 74 in the interactive database.

Description as filed by funds: Election of Directors: Paul Meister

AMNEAL PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Paul Meister”): 239,786,615 for, 20,307,492 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the proposals was approved, and each of the director nominees was elected, by the vote of the stockholders at the Annual Meeting as follows: Proposal 1 : To elect the following director nominees to hold office until the 2025 Annual Meeting of Stockholders and until their respective successo…”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 36,689,830 for, 7,958,285 against, 192,019 abstained.

Showing the 25 largest of 74 asset managers. See all 74 in the interactive database.

Description as filed by funds: Election of Directors: Shlomo Yanai

AMNEAL PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Shlomo Yanai”): 258,502,824 for, 1,791,220 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the proposals was approved, and each of the director nominees was elected, by the vote of the stockholders at the Annual Meeting as follows: Proposal 1 : To elect the following director nominees to hold office until the 2025 Annual Meeting of Stockholders and until their respective successo…”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 44,590,639 for, 249,495 against.

Showing the 25 largest of 74 asset managers. See all 74 in the interactive database.

Description as filed by funds: Election of Directors: Ted Nark

AMNEAL PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Ted Nark”): 257,861,624 for, 2,225,579 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the proposals was approved, and each of the director nominees was elected, by the vote of the stockholders at the Annual Meeting as follows: Proposal 1 : To elect the following director nominees to hold office until the 2025 Annual Meeting of Stockholders and until their respective successo…”
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 44,485,564 for, 162,551 against, 192,019 abstained.

Showing the 25 largest of 74 asset managers. See all 74 in the interactive database.

Description as filed by funds: Advisory vote to approve executive compensation.

AMNEAL PHARMACEUTICALS INC.’s own tally for this item (“2. To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers”): 258,800,579 for, 1,255,182 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 72 managers: 44,605,921 for, 15,590 against, 210,000 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 170 managers: 68,034,478 for, 356,718 against, 5,974 abstained, 72,722 1 year. Showing the 25 largest; see all in the interactive database.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports, all 72 managers: 65,944 for, 40,493,890 1 year, 4,061,677 3 year, 210,000 unknown. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 158 managers: 80,966 for, 63,077,116 1 year, 835,557 3 year. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal 2025.

AMNEAL PHARMACEUTICALS INC.’s own tally for this item (“4. To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025”): 288,989,309 for, 452,503 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 44,839,058 for, 1,076 against.

Showing the 25 largest of 74 asset managers. See all 74 in the interactive database.